BigHat Biosciences

AI-guided antibody design platform. Protein therapeutics company developing next-generation antibody drugs. Partnered with Eli Lilly. San Francisco Bay Area. Leadership (added 2026-06-10, source: https://www.bighatbio.com/about): Nicholas Young Scientist II (Senior Director, Antibody Engineering)